Drug Intell Clin Pharm. 1986 Apr;20(4):289-91.
Possible risk of invasive pulmonary aspergillosis with marijuana use during chemotherapy for small cell lung cancer.
Sutton S, Lum BL, Torti FM.

Bacterial and fungal contaminants have been identified in marijuana samples and thus are a potential risk factor in the immunocompromised patient using it as an antiemetic. We describe the development of an invasive pulmonary aspergillosis in a patient using illicitly obtained marijuana as an antiemetic during combination antitumor therapy for small cell lung cancer. Although this patient had multiple risk factors implicated in the development of invasive pulmonary aspergillosis, the infectious potential of inhaled marijuana must be recognized. Further study of this potential health risk in needed.

PMID: 3009125 [PubMed - indexed for MEDLINE]

Related Articles

* Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancer. [J Clin Oncol. 2008]
* [Invasive aspergillar pneumopathy during the treatment of microcellular bronchial cancer. Efficacy of early antifungal treatment] [Rev Mal Respir. 1985]
* [Pulmonary aspergillosis in the neutropenic patient. Apropos of 4 cases] [Tunis Med. 1996]
* Pseudomembranous tracheobronchial aspergillosis: a rare manifestation of invasive aspergillosis in a non-neutropenic patient with Hodgkin's disease. [Mycoses. 2003]
* Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. [Transplantation. 1996]